I spoke on a panel recently on the topic of all things privacy and biometrics. The Biometrics Institute hosted the discussion at the Australian Embassy in Washington, DC. The panel discussion was subject to Chatham House rules, and, in order to foster open dialogue, the audience did not include any members of the press. The
Many people have told us that they think opting out is confusing. We agree. Opting out can range from the not-too-difficult (the FTC’s Do Not Call list is a fairly simple opt out) to the challenging (the National Advertising Initiative opt out can be tricky). Our hope is that this list will clarify which opt out does what, and how to go about opting out.
On Christmas Eve, the US National Security Agency (NSA) declassified and released 12 years of reports outlining compliance violations that were submitted to the NSA Intelligence Oversight Committee. The reports, which are required by law, had previously been classified and were the subject of a legal battle between the ACLU and the government. Although heavily redacted, the reports the NSA released of are vital interest to the public because they reveal a pattern of significant privacy violations and in some cases serious abuses in granular detail.
Today, health insurers Blue Shield of California and Anthem Blue Cross announced the creation of a statewide database of patient medical records in California called Cal INDEX. When it launches later this year, it will be the country’s largest health information exchange, or HIE. The exchange is set to disseminate patient’s longitudinal medical files, and
The World Privacy Forum’s recent public comments to the White House regarding Big Data focus on using a foundation of Fair Information Principles to address issues connected to bias, error, and privacy regarding big data as applied to vulnerable populations. The comments also discuss large medical research data sets, and stress the importance of applying